奥美沙坦酯杂质I

奥美沙坦酯杂质I性质、用途与生产工艺

生物活性

奥美沙坦酯杂质I 上下游产品信息

上游原料

下游产品

奥美沙坦酯杂质I 生产厂家

879562-26-2, 奥美沙坦酯杂质I 相关搜索:

• Pharmaceuticals
• Nucleotides
• Intermediates & Fine Chemicals
• Intermediates
• Heterocycles
• Bases & Related Reagents
• Aromatics
• 化工试剂
• 标准品
• 医药原料
• 杂质对照品
• 氨基酸
• 奥美沙坦酯RNH-6373
• (5-甲基-2-氧代-1,3-二氧代-4-基)甲基 1-((2'-(2H-四唑-5-基)-[1,1'-联苯]-4-基)甲基)-4-(丙-1-烯-2-基)-2-丙基-1H-咪唑-5-羧酸酯
• 4-(1-甲基乙烯基)-2-丙基-1-[[2'-(2H-四唑-5-基)[1,1'-联苯]-4-基] 甲基]-1H-咪唑-5-羧酸,(5-甲基-2-氧代-1,3-二氧六环-4-基) 甲酯
• OLMESARTAN杂质3(奥美沙坦酯EP杂质C)
• 奥美沙坦酯杂质02
• 1-[[2'-(5-四唑基)-4-联苯基]甲基]-4-(1-丙烯-2-基)-2-丙基咪唑-5-甲酸((5-甲基-2-氧代-1,3-二噁茂-4-基)甲基)酯
• (5-甲基-2-氧代-1,3-二氧杂-4-基)甲基1-((2'-(2H-四唑-5-基)-[1,1'-联苯] -4-基) 甲基)-4-(丙-1-烯-2-基)-2-丙基-1H-咪唑
• 4-(1-甲基乙烯基)-2-丙基-1-[[2'-(2H-四唑-5-基)[1,1'-联苯]-4-基] 甲基]-1H-咪唑-5-羧酸,(5-甲基-2-氧代-1,3-二氧六环-4-基) 甲酯
• RNH-6373
• 奥美沙坦酯杂质239
• 奥美沙坦酯杂质C RNH-6373
• (5-甲基-2-氧代-1,3-二氧杂-4-基)甲基 1-((2'-(2H-四唑-5-基)-[1,1'-联苯]-4-基)甲基)-4-(丙-1-烯-2-基)-2-丙基-1H-咪唑-5-羧酸酯
• OLMESARTAN MEDOXOMIL DEHYDRO; OLMESARTAN MEDOXOMIL EP IMPURITY C
• OLMESARTAN MEDOXOMIL EP杂质 C
• 4-(1-甲基乙烯)-2-丙基-1-[[2-(2H-四ZOL-5-基)[1,1-联苯]-4-基]甲基]-1H-咪唑-5-羧酸(5-甲基-2-氧代-1,3-二氧代L-4-基)甲酯
• 奥美沙坦酯杂质C (EP)
• 奥美沙坦杂质I
• 奥美沙坦酯杂质I
• 奥美沙坦酯EP杂质C
• 美沙坦酯杂质C
• 奥美沙坦EP杂质C
• 奥美沙坦酯杂质C
• 879562-26-2
• Olmesartan ester impurity C
• Olmesartan Medoxomil Olefinic Impurity (USP)
• Olmesartan EP Impurity C Dehydro Olmesartan Medoxomil
• (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
• 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
• (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl) -[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidaze -5-carboxylate
• Anhydro Olmesartan Medoxomil
• Olmesartan EP imp C
• (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-[[2’-(5-Tetrazolyl)-4-biphenylyl]methyl]-4-(1-propen-2-yl)-2-propylimidazole-5-carboxylate
• Olmesartan Medoxomilum EP Impurity C
• Olmesartan Medoxomil EP Impurity C, RNH-6373
• (5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL 1-((2-(2H-TETRAZOL-5-YL)-[1,1-BIPHENYL]-4-YL)METHYL)-4-(PROP-1-EN-2-YL)-2-PROPYL-1H-IMIDAZOLE-5-CARBOXYLATE
• Olmesartan Medoxomil Impurity C
• Olmesartan Medoxomil impurity 12/Olmesartan Medoxomil EP Impurity C/Dehydro Olmesartan Medoxomil/(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2-(2H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
• (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-prop-1-en-2-yl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
• DES(1-hydroxy-1-methylethyl)-(1-methylethenyl)-olmesartan medoxomil
• Olmesartan Medoxomil-3
• Azilsartan medoxomil impurity239
• 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-...
• Olmesartan EP Impurity C/ Olmesartan Medoxomil Olefinic Impurity USP (Dehydro Olmesartan Medoxomil/ Anhydro Olmesartan Medoxomil)
• (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(pro
• 1H-Imidazole-5-carboxylic acid, 4-(1-methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
• Olmesartan Medoxomil Impurity RNH-6270（4-（1-hydroxy-1-methylethyl）-2-propyl-1-[[2’-（1H-tetrazol-5-yl）biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic acid）